Cognitive behavioral therapy (CBT) is a brief, efficient, and effective treatment for individuals with depressive/anxiety disorders. However, CBT is largely underutilized within the Department of Veterans Affairs due to the cost and burden of trainings necessary to deliver all of the related disorder-specific treatments (DSTs). Transdiagnostic Behavior Therapy (TBT), in contrast, is specifically designed to address numerous distinct disorders within a single protocol in Veterans with depressive/anxiety disorders. The proposed research seeks to evaluate the efficacy of TBT by assessing psychiatric symptomatology and related impairment outcomes in Veterans with social anxiety disorder and comorbid posttraumatic stress via a randomized controlled trial of TBT and an existing DST. Assessments will be completed at pre-, mid-, and post-treatment, and at 6-month follow-up. Process variables also will be investigated.
Participants must be Veterans and registered at Ralph H. Johnson Veterans Affairs Health Care System
Participants must be clearly competent to provide informed consent for research participation
Participants must meet DSM-5 criteria for social anxiety disorder
Participants must have clinically significant symptoms of comorbid posttraumatic stress
recent history (< 2 months) of psychiatric hospitalization or a suicide attempt as documented in their medical record,
acute, severe illness or medical condition that likely will interfere with study procedures as documented in their medical record
recent start of new psychiatric medication(s) (< 4 weeks),
primary diagnosis of a condition associated with psychotic symptoms, personality disorder, substance use disorder, or bipolar disorder.